Investigators observed that anti-cancer efficacy without concomitant autoimmunity was due to lineage-specific induction of CD8+ T-cell responses to GUCY2C, without CD4+ helper T-cell or antibody responses [21]. Here, CD4 is linked to Autoimmunity.